Asthma Clinical Trials in New York

Showing 401-420 of 435 trials

Study of Acid Reflux in Asthma

NCT00069823

The purpose of this study is to determine if subjects with symptomatic asthma who are assigned to treatment with a proton pump inhibitor (PPI) drug such as Nexium have fewer asthma attacks than similar subjects assigned to placebo treatment.

AsthmaLung DiseasesLung Diseases, Obstructive

Johns Hopkins Bloomberg School of Public Health403 participantsStarted Sep 2003

Birmingham, Alabama, United States • San Diego, California, United States • Denver, Colorado, United States +17 more locations

COMPLETEDPhase 4< 1 mile

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

NCT00702325

To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.

Asthma

AstraZeneca311 participantsStarted Jun 2008

Pell City, Alabama, United States • Bentonville, Arkansas, United States • Hot Springs, Arkansas, United States +54 more locations

Study of Acid Reflux in Asthma

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

Asthma Trials in Other Cities

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

Calfactant for Direct Acute Respiratory Distress Syndrome

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

Study of Daclizumab in Patients With Chronic, Persistent Asthma

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

Other Conditions in New York